US healthcare company CVS Health Corporation (NYSE: CVS) announced on Monday that its board of directors has approved a quarterly dividend of sixty-six and one-half cents (USD0.665) per share on the Common Stock of the Corporation.
The dividend is payable on 1 August 2025, to holders of record on 22 July 2025.
According to CVS Health, as of 31 March 2025 it has more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a pharmacy benefits manager with approximately 88 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year.
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Ridgetech reports net income of USD10.20m in fiscal year 2025
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea